The $100m telehealth corporate prescribing compounded semaglutide — its top GP speaks with AusDoc
The TGA is considering a ban on compounded semaglutide, but Dr Matt Vickers says that would not halt the model of care.
Telehealth corporate Eucalyptus is making headlines for prescribing off-label compounded semaglutide as part of an online weight loss program that costs up to $599 a month.
The RACGP has accused Eucalyptus of undermining holistic GP care.
And the TGA is threatening a ban on semaglutide compounding because of patient safety fears.
None of this has put off the investors — including Woolworths Group and the investment firm Blackbird, co-founded by billionaire Mike Cannon-Brookes.
